Immunogenic potential of a Salmonella Typhimurium live vaccine for pigs against monophasic Salmonella Typhimurium DT 193

Abstract Background Monophasic Salmonella Typhimurium (mSTM) strains account for up to 8.6% of all human Salmonellosis cases. They have an increasing prevalence during recent years and several human cases with hospitalisation were reported. These strains are often isolated from pigs and pork - one p...

Full description

Bibliographic Details
Main Authors: Tobias Theuß, Elke Ueberham, Jörg Lehmann, Thomas Lindner, Sven Springer
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Veterinary Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12917-017-1271-5
_version_ 1819059860800536576
author Tobias Theuß
Elke Ueberham
Jörg Lehmann
Thomas Lindner
Sven Springer
author_facet Tobias Theuß
Elke Ueberham
Jörg Lehmann
Thomas Lindner
Sven Springer
author_sort Tobias Theuß
collection DOAJ
description Abstract Background Monophasic Salmonella Typhimurium (mSTM) strains account for up to 8.6% of all human Salmonellosis cases. They have an increasing prevalence during recent years and several human cases with hospitalisation were reported. These strains are often isolated from pigs and pork - one primary source of human infection. A Salmonella Typhimurium (STM) live vaccine has been proven successful in controlling of STM infections in pigs for many years. The aim of this study was to test the immunogenicity of the vaccine in weaners during oral challenge with a virulent mSTM strain and to examine the kinetics of STM-specific IgA, IgM and IgG antibodies induced by vaccination and infection. Results Despite clinical signs being present in both groups, the vaccination led to a significant reduction of diarrhoea, overall clinical symptoms and a milder elevation of the body temperature. Necropsy revealed fewer pathological lesions in the gastrointestinal tract of vaccinated compared to control animals. Moreover, in the ileal and caecal mucosa and in the ileocaecal lymph nodes the challenge strain burden was significantly reduced by vaccination. Significant differences in the antibody responses of both groups were present during the vaccination period and after infection. In vaccinated animals Salmonella-specific IgA and IgG antibody levels increased significantly after vaccination and were even more pronounced in response to challenge. In contrast, similarly low levels of IgM antibodies were detected during the vaccination period in both vaccinated and non-vaccinated animals. However, after challenge IgM antibody levels increased significantly in control pigs while neither IgA nor IgG antibodies were detectable. Conclusion The data demonstrate that mSTM can evoke clinical signs in weaners. Due to the vaccination their incidence and magnitude were significantly milder. Vaccination also led to a significantly reduced challenge strain burden in the intestine and the lymph nodes which is comparable to previous studies using the same vaccine in a challenge with biphasic STM. Therefore, it is concluded that this vaccine induces immunity against monophasic and biphasic STM strains. Furthermore, the results of antibody profiles in response to vaccination and infection provide additional evidence for humoral immune mechanisms triggered during Salmonella infection or vaccination.
first_indexed 2024-12-21T14:17:49Z
format Article
id doaj.art-463ecdbb3c584d3a891f0aa9952f80ff
institution Directory Open Access Journal
issn 1746-6148
language English
last_indexed 2024-12-21T14:17:49Z
publishDate 2017-11-01
publisher BMC
record_format Article
series BMC Veterinary Research
spelling doaj.art-463ecdbb3c584d3a891f0aa9952f80ff2022-12-21T19:00:51ZengBMCBMC Veterinary Research1746-61482017-11-011311810.1186/s12917-017-1271-5Immunogenic potential of a Salmonella Typhimurium live vaccine for pigs against monophasic Salmonella Typhimurium DT 193Tobias Theuß0Elke Ueberham1Jörg Lehmann2Thomas Lindner3Sven Springer4IDT Biologika GmbH, Business Unit Animal Health, Research and DevelopmentFraunhofer Institute for Cell Therapy and ImmunologyFraunhofer Institute for Cell Therapy and ImmunologyIDT Biologika GmbH, Business Unit Animal Health, Research and DevelopmentIDT Biologika GmbH, Business Unit Animal Health, Research and DevelopmentAbstract Background Monophasic Salmonella Typhimurium (mSTM) strains account for up to 8.6% of all human Salmonellosis cases. They have an increasing prevalence during recent years and several human cases with hospitalisation were reported. These strains are often isolated from pigs and pork - one primary source of human infection. A Salmonella Typhimurium (STM) live vaccine has been proven successful in controlling of STM infections in pigs for many years. The aim of this study was to test the immunogenicity of the vaccine in weaners during oral challenge with a virulent mSTM strain and to examine the kinetics of STM-specific IgA, IgM and IgG antibodies induced by vaccination and infection. Results Despite clinical signs being present in both groups, the vaccination led to a significant reduction of diarrhoea, overall clinical symptoms and a milder elevation of the body temperature. Necropsy revealed fewer pathological lesions in the gastrointestinal tract of vaccinated compared to control animals. Moreover, in the ileal and caecal mucosa and in the ileocaecal lymph nodes the challenge strain burden was significantly reduced by vaccination. Significant differences in the antibody responses of both groups were present during the vaccination period and after infection. In vaccinated animals Salmonella-specific IgA and IgG antibody levels increased significantly after vaccination and were even more pronounced in response to challenge. In contrast, similarly low levels of IgM antibodies were detected during the vaccination period in both vaccinated and non-vaccinated animals. However, after challenge IgM antibody levels increased significantly in control pigs while neither IgA nor IgG antibodies were detectable. Conclusion The data demonstrate that mSTM can evoke clinical signs in weaners. Due to the vaccination their incidence and magnitude were significantly milder. Vaccination also led to a significantly reduced challenge strain burden in the intestine and the lymph nodes which is comparable to previous studies using the same vaccine in a challenge with biphasic STM. Therefore, it is concluded that this vaccine induces immunity against monophasic and biphasic STM strains. Furthermore, the results of antibody profiles in response to vaccination and infection provide additional evidence for humoral immune mechanisms triggered during Salmonella infection or vaccination.http://link.springer.com/article/10.1186/s12917-017-1271-5Salmonella TyphimuriumVaccinationInfectionSalmoporcIgMIgA
spellingShingle Tobias Theuß
Elke Ueberham
Jörg Lehmann
Thomas Lindner
Sven Springer
Immunogenic potential of a Salmonella Typhimurium live vaccine for pigs against monophasic Salmonella Typhimurium DT 193
BMC Veterinary Research
Salmonella Typhimurium
Vaccination
Infection
Salmoporc
IgM
IgA
title Immunogenic potential of a Salmonella Typhimurium live vaccine for pigs against monophasic Salmonella Typhimurium DT 193
title_full Immunogenic potential of a Salmonella Typhimurium live vaccine for pigs against monophasic Salmonella Typhimurium DT 193
title_fullStr Immunogenic potential of a Salmonella Typhimurium live vaccine for pigs against monophasic Salmonella Typhimurium DT 193
title_full_unstemmed Immunogenic potential of a Salmonella Typhimurium live vaccine for pigs against monophasic Salmonella Typhimurium DT 193
title_short Immunogenic potential of a Salmonella Typhimurium live vaccine for pigs against monophasic Salmonella Typhimurium DT 193
title_sort immunogenic potential of a salmonella typhimurium live vaccine for pigs against monophasic salmonella typhimurium dt 193
topic Salmonella Typhimurium
Vaccination
Infection
Salmoporc
IgM
IgA
url http://link.springer.com/article/10.1186/s12917-017-1271-5
work_keys_str_mv AT tobiastheuß immunogenicpotentialofasalmonellatyphimuriumlivevaccineforpigsagainstmonophasicsalmonellatyphimuriumdt193
AT elkeueberham immunogenicpotentialofasalmonellatyphimuriumlivevaccineforpigsagainstmonophasicsalmonellatyphimuriumdt193
AT jorglehmann immunogenicpotentialofasalmonellatyphimuriumlivevaccineforpigsagainstmonophasicsalmonellatyphimuriumdt193
AT thomaslindner immunogenicpotentialofasalmonellatyphimuriumlivevaccineforpigsagainstmonophasicsalmonellatyphimuriumdt193
AT svenspringer immunogenicpotentialofasalmonellatyphimuriumlivevaccineforpigsagainstmonophasicsalmonellatyphimuriumdt193